This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Research On China's Medical Monitor Market, 2013-2017

NEW YORK, March 26, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Research on China's Medical Monitor Market, 2013-2017 http://www.reportlinker.com/p01144167/Research-on-China's-Medical-Monitor-Market-2013-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply

Please note: The report is Chinese version. It will provide the English version in two business days

The high-end technologies of global medical monitor products are mainly mastered by the United States, Japan, Germany, the Netherlands and a few other western developed countries; and most of the developing countries which are represented by China, India and Brazil still take conventional medical monitoring technology as the development key point.

From the brand perspective, the key brands of global medical monitors are PHILIPS ( Netherlands), GE ( the United States) and Mindray ( Shenzhen, China); the market share of these three enterprises occupy more than a half of the global market, and the market shows oligopoly pattern.

China's application of medical monitors started from the monitoring of cardiovascular diseases. At present, the medical monitors have been widely used for cardiovascular, respiratory, maternity, newborn, anesthesia and sleep monitoring. The single discipline has developed into multi-disease entities, multi-departments and multidisciplinary applications; and the applications also expanded to medium and small-scale hospitals from large-scale hospitals. Medical monitor is turning into a conventional method, and is expanding the application areas at a rapid rate.

China's medical monitor market owns relatively high concentration ratio; there are about 70 medical monitor enterprises in China, of which, about ten of them have independent R&D capability. The domestic market can be divided into two plates: the first plate is represented by Philips, GE and Mindray; these enterprises own absolute advantage in the aspects of market share and turnover by virtue of strong capital strength, abundant medical devices variety and wide range of sales channels; the second plate is represented by Biolight and Creative, which focus on the development and marketing of medical monitors; they can meet the individual needs of different customers by virtue of unique technologies and products.

In 2012, the scale of China's medical monitor market has reached CNY 3.01 billion; the popularizing rate has made substantial progress, and the popularizing rate in some developed cities and regions reached 25.4%.

As for the service condition in current medical monitor market, the proportion of high-end products and conventional products is about 4:6. Taking technical update cycle into account, it is estimated that this proportion will remain relatively stable in the next five years. However, as for the long-term development, plug-in type monitor and other high-end products will become the mainstream with the further enhance of industry R&D capability and the further improvement of China's medical security system.

1. Overview of China's Medical Monitors 1.1 Definition and Classification 1.1.1 Definition 1.1.2 Classification 1.2 Industry Cycle

2. Development Overview of Overseas Medical Monitor Market 2.1 Analysis of Global Medical Monitor Market 2.2 Competitive Situation 2.3 Market Overview in Major Countries and Regions 2.3.1 Continuous Growth in U.S. Patient Monitoring Market 2.3.2 European Monitor Market

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,794.54 -15.52 -0.09%
S&P 500 2,067.14 +3.64 0.18%
NASDAQ 4,747.4140 +34.4440 0.73%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs